Skip to content
MedsAcross

Brand family

Marcaine

Bupivacaine · Hospira
United States
Presentations
6
Markets
1

Marcaine is a brand of Bupivacaine marketed by Hospira, with 6 presentations listed and registered in United States. Each presentation below has its own page with packs, documents and availability for export supply from India.

Active ingredient (INN)
Bupivacaine
Brand owner
Hospira
Registered in
United States
Strengths and forms
150 mg/30 mL injection, 225 mg/30 mL injection, 25 mg/10 mL injection, 250 mg/50 mL injection, 50 mg/10 mL injection, 75 mg/30 mL injection

All presentations

MedicineManufacturerRegisterAvailability
Marcaine 150 mg/30 mL injectionEpidural, intracaudal, perineuralHospiraUS FDAAvailable on request
Marcaine 225 mg/30 mL injectionEpidural, retrobulbarHospiraUS FDAAvailable on request
Marcaine 25 mg/10 mL injectionEpidural, infiltration, intracaudal, perineuralHospiraUS FDAAvailable on request
Marcaine 250 mg/50 mL injectionPerineuralHospiraUS FDAAvailable on request
Marcaine 50 mg/10 mL injectionEpidural, intracaudal, perineuralHospiraUS FDAAvailable on request
Marcaine 75 mg/30 mL injectionEpidural, infiltration, intracaudal, perineuralHospiraUS FDAAvailable on request

Equivalent brands

Other brands of Bupivacaine.

Brand names and trademarks belong to their owners and are used only to identify products.

Request Marcaine

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.